Bromelain

Common name

pineapple extract

ID

HD0102

Scientific name of the plant

Ananas comosus

Anatomical part for use

N/A

Human use

Pain and inflammation

Summary

Bromelain is an enzyme extract derived from the stems of pineapples, although it exists in all parts of the fresh pineapple. The extract has a history of folk medicine use. As an ingredient, it is used in cosmetics, as a topical medication, and as a meat tenderizer.The term "bromelain" may refer to either of two protease enzymes extracted from the plants of the family Bromeliaceae, or it may refer to a combination of those enzymes along with other compounds produced in an extract. Bromelain enzymes are called fruit bromelain and stem bromelain.Although tested in a variety of folk medicine and research models for its possible efficacy against diseases, bromelain has as its only approved clinical application, issued in 2012 by the European Medicines Agency, a topical medication called NexoBrid, used to remove dead tissue in severe skin burns.

Evidence Level

Level 0 (No convinced report of liver injury caused by herbal and dietary supplement)

Hepatotoxicity Description

N/A

Potential medical uses

Bromelain has not been scientifically proven to be effective in treating any diseases and has not been approved by the U.S. Food and Drug Administration for the treatment of any disorder. In the United States, the passage of the Dietary Supplement Health and Education Act (DSHEA, 1994) allows the sale of bromelain-containing dietary supplements, even though efficacy has not been confirmed. Ingestion of bromelain may cause an allergic reaction in some people who are sensitive to pineapples.While there have been studies into the medical use of bromelain, "the majority of [them] have methodological issues that make it difficult to draw definite conclusions", as none definitively established efficacy, recommended dosage, long term safety, or adverse interaction with other medications.A concentrate of proteolytic enzymes enriched in bromelain is approved in Europe for the debridement (removal of dead tissue) of severe burn wounds under the trade name NexoBrid. Systemic enzyme therapy (consisting of combinations of proteolytic enzymes such as bromelain, trypsin, chymotrypsin, and papain) has been investigated in Europe to evaluate the efficacy in breast, colorectal, and plasmacytoma cancer patients. Bromelain may be effective as an adjunct therapy in relieving symptoms of acute rhinosinusitis in patients not treated with antibiotics. (Source: Wiki)

Relevant Public Information

Wiki
NIH ODS
Nature Medicines